| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/05/2006 | EP1675622A2 Multi-arm polymer prodrugs |
| 07/05/2006 | EP1675621A2 Pharmaceutical compositions of lavendustin |
| 07/05/2006 | EP1675620A2 Polymer derivatives |
| 07/05/2006 | EP1675619A1 Sustained release l-arginine formulations and methods of manufacture and use |
| 07/05/2006 | EP1675618A1 Elutable surface coating |
| 07/05/2006 | EP1675612A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 07/05/2006 | EP1675606A2 Peptides and compounds that bind to thrombopoietin receptors |
| 07/05/2006 | EP1675599A1 Pharmaceutical composition comprising oxoplatin, the salts and derivatives thereof |
| 07/05/2006 | EP1675577A2 Patch |
| 07/05/2006 | EP1675573A2 Controlled release sterile injectable aripiprazole formulation and method |
| 07/05/2006 | EP1675569A1 Delivery of therapeutic compounds via microparticles or microbubbles |
| 07/05/2006 | EP1675563A1 Emulsive composition containing dapsone |
| 07/05/2006 | EP1675555A2 Pharmaceutical compositions for prevention of overdose or abuse |
| 07/05/2006 | EP1467744A4 Aqueous compositions containing metronidazole |
| 07/05/2006 | EP1418881A4 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 07/05/2006 | EP1368040B1 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/05/2006 | EP1326644B1 Absorption enhancers |
| 07/05/2006 | EP1274473B1 Antimicrobial bioabsorbable materials |
| 07/05/2006 | EP1235900B1 Microparticle-based transfection and activation of dendritic cells |
| 07/05/2006 | EP1183026B1 Improved pharmaceutical formulations comprising ritonavir |
| 07/05/2006 | EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment |
| 07/05/2006 | EP1044005B1 1,2,4-benzotriazine oxides formulations |
| 07/05/2006 | EP1039905B1 Pharmaceutical formulation comprising glycine as a stabilizer |
| 07/05/2006 | EP1028727B1 Skin penetration enhancing components |
| 07/05/2006 | EP1027038B1 Taste masked pharmaceutical compositions |
| 07/05/2006 | CN2792500Y Oral insulin corpuscle |
| 07/05/2006 | CN1799002A Laser projector |
| 07/05/2006 | CN1798796A 纤维素粉末 Cellulose powder |
| 07/05/2006 | CN1798754A Synthesis of high molecular weight iron-saccharidic complexes |
| 07/05/2006 | CN1798603A Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
| 07/05/2006 | CN1798578A Medicinal compositions for improving oral absorption |
| 07/05/2006 | CN1798575A 高浓度抗体和蛋白制剂 High concentrations of antibody and protein formulations |
| 07/05/2006 | CN1798564A Topical blood pressure composition |
| 07/05/2006 | CN1798563A Immunostimulant |
| 07/05/2006 | CN1798562A Composition for oral administration containing itraconazole |
| 07/05/2006 | CN1798549A Stabilized aerosol dispersions |
| 07/05/2006 | CN1798547A Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 07/05/2006 | CN1798546A Process for producing microparticles |
| 07/05/2006 | CN1798545A Method for improving stability and shelf-life of liposome complexes |
| 07/05/2006 | CN1798543A Stabilized particle dispersions containing nanoparticles |
| 07/05/2006 | CN1795977A Preparation method for loading functional in organic micromolecules |
| 07/05/2006 | CN1795927A Composite of total flavone phospholipid of safflower, and preparation method |
| 07/05/2006 | CN1795922A Agent promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin |
| 07/05/2006 | CN1795913A Medicament drop pills for nourish qi and yin, recovering channels and vessels, and increasing the body fluid, and preparation method |
| 07/05/2006 | CN1795892A Oral taking composition for covering unfavored taste of extractive of Chinese traditional medicine |
| 07/05/2006 | CN1795881A Composite of total flavone phosphatide of seabuckthorn, and preparation method |
| 07/05/2006 | CN1795866A Complex of total flavone phospholipid of blackberry lily and preparation method |
| 07/05/2006 | CN1795860A Oral taking chewy composition for covering unflavored taste and preparation method |
| 07/05/2006 | CN1795857A Composition for covering flavor and preparation of containing the composition |
| 07/05/2006 | CN1795768A Oxidation resistant composition |
| 07/05/2006 | CN1795767A Oxidation resistant composition |
| 07/05/2006 | CN1262668C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/05/2006 | CN1262665C Code-optimized papilloma virus sequences |
| 07/05/2006 | CN1262561C Synthetic poly peptide disturbing intracelluler signaling |
| 07/05/2006 | CN1262311C Medicinal composition for target direction transport curing cancer and its usage |
| 07/05/2006 | CN1262310C Multifunctional depot type medicine carrier and preparation method thereof |
| 07/05/2006 | CN1262289C Application of antimonocytic activity of extracts of piper betel leaves |
| 07/05/2006 | CN1262278C Antiacid and laxative tablets |
| 07/05/2006 | CN1262274C Complexes of phosphate derivatives |
| 07/05/2006 | CN1262213C Water containing soluble fiber |
| 07/04/2006 | US7071235 Latent reactive blood compatible agents |
| 07/04/2006 | US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/04/2006 | US7071004 Isolated nucleic acids; uisng gene expression as indicator of cancer; insertion gene in transgenic animals |
| 07/04/2006 | US7070991 Cells expressing a CD4-IgG2 chimeric heterotetramer |
| 07/04/2006 | US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis |
| 07/04/2006 | US7070828 Process for coating solid particles |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070812 Process for producing dry powders of one or more carotenoids |
| 07/04/2006 | US7070810 Use of buckysome or carbon nanotube for drug delivery |
| 07/04/2006 | US7070809 Hydrogel biomedical articles |
| 07/04/2006 | US7070808 Comprising an adhesive, drug in protonated form, a nonaqueous solvent capable of dissolving nonprotonated and protonated forms of the drug, and a biocompatible deprotonating agent to deprotonate the drug without irritating the skin |
| 07/04/2006 | US7070807 Administering polypeptide by injection; gene therapy |
| 07/04/2006 | US7070805 Comprises a pharmacologically active ingredient, a sugar and a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropyl group; fast disintegrability, suitable strength and no roughness |
| 07/04/2006 | US7070801 Drug delivery system |
| 07/04/2006 | US7070800 Inhalable powder containing tiotropium |
| 07/04/2006 | US7070787 Relates to immunogen for inducing antibodies that neutralize a wide spectrum of HIV primary isolates and method of inducing anti-HIV antibodies using such immunogen |
| 07/04/2006 | US7070781 Nontoxic mucosal adjuvant |
| 07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
| 07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
| 07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
| 07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
| 07/04/2006 | US7070722 for medical or veterinary use; gelling agent treated with a first precipitant which is calcium citrate and/or calcium-releasing water-soluble glass to stabilize the gelling agent; foaming and curing; immersing foam in a second calcium precipitant; sterlizing with gamma radiation or ethylene oxide |
| 07/04/2006 | US7070592 Medical device with array of electrode-containing reservoirs |
| 07/04/2006 | CA2462452C Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| 07/04/2006 | CA2414945C Cellulose powder |
| 07/04/2006 | CA2267091C Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
| 07/04/2006 | CA2159419C Solid pharmaceutical composition comprising an excipient capable of binding water |
| 06/29/2006 | WO2006069388A2 Stabilized polymeric thiol reagents |
| 06/29/2006 | WO2006068899A2 Preserved ophthalmic compositions comprising aloe vera |
| 06/29/2006 | WO2006068867A1 Combination therapy for b cell disorders |
| 06/29/2006 | WO2006068596A1 Solid dosage form comprising proton pump inhibitor and suspension made thereof |
| 06/29/2006 | WO2006068346A1 Biopolymer and gene complex |
| 06/29/2006 | WO2006068266A1 PROSTAGLANDIN F2α DERIVATIVE CONTAINING PRODUCTS |
| 06/29/2006 | WO2006068232A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | WO2006068166A1 Dry granulated substance and process for producing the same |
| 06/29/2006 | WO2006067608A1 Aqueous formulations based on sodium hyaluronate for parenteral use |
| 06/29/2006 | WO2006067502A1 Treatment of inflammatory diseases |
| 06/29/2006 | WO2006067173A2 Antithrombotic dual inhibitors comprising a biotin residue |